down arrow

TTK Healthcare

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE910C01018
  • NSEID: TTKHLTCARE
  • BSEID: 507747
INR
1,200.00
36.75 (3.16%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 1.98 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

1.98 k (-50.44%) Volume

Shareholding (Dec 2024)

FII

1.90%

Held by 10 FIIs

DII

1.14%

Held by 0 DIIs

Promoter

74.56%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
1

  • The promoters of TTK Healthcare are exploring voluntary delisting of the company and have announced a floor price of Rs 1201.3. If the promoter accepts the discovered price through reverse book building it would be delisted or else the company will continue to be listed
2

Poor long term growth as Net Sales has grown by an annual rate of 4.07% and Operating profit at 4.66% over the last 5 years

 
3

Flat results in Dec 24

4

Stock is technically in a Bearish range

5

Despite the size of the company, domestic mutual funds hold only 0.01% of the company

6

Underperformed the market in the last 1 year

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 1,696 Cr (Small Cap)

stock-summary
P/E

24.00

stock-summary
Industry P/E

33

stock-summary
Dividend Yield

0.86%

stock-summary
Debt Equity

-0.73

stock-summary
Return on Equity

6.59%

stock-summary
Price to Book

1.58

Revenue and Profits (1 Year):
Net Sales:
205 Cr
(Quarterly Results - Dec 2024)
Net Profit:
17 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0.86%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
-27.69%
0%
-27.69%
1 Year
-24.7%
0.64%
-24.06%
2 Years
-8.35%
1.62%
-6.73%
3 Years
48.76%
4.07%
52.83%
4 Years
134.4%
6.31%
140.71%
5 Years
180.54%
9.21%
189.75%

Latest dividend: 10 per share ex-dividend date: Jul-16-2024

Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
4.07%
EBIT Growth (5y)
4.66%
EBIT to Interest (avg)
6.37
Debt to EBITDA (avg)
0.76
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
1.38
Tax Ratio
24.39%
Dividend Payout Ratio
22.49%
Pledged Shares
0
Institutional Holding
3.04%
ROCE (avg)
-64.75%
ROE (avg)
20.09%
Valuation key factors
Factor
Value
P/E Ratio
24
Industry P/E
33
Price to Book Value
1.58
EV to EBIT
34.24
EV to EBITDA
25.03
EV to Capital Employed
3.18
EV to Sales
1.11
PEG Ratio
3.57
Dividend Yield
0.86%
ROCE (Latest)
8.02%
ROE (Latest)
6.59%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 2 Schemes (0.0%)

FIIs

Held by 10 FIIs (1.9%)

Promoter with highest holding

T T Krishnamachari & Co. Represented By Its Partners - Mr T T Jagannathan And Mr T T Raghunathan (67.46%)

Highest Public shareholder

Jupiter India Fund (1.52%)

Individual Investors Holdings

16.2%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Dec'24 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Dec 2024 is 11.36% vs 0.71% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in quarter ended Dec 2024 is 29.79% vs 7.42% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "204.74",
          "val2": "183.85",
          "chgp": "11.36%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "7.69",
          "val2": "5.34",
          "chgp": "44.01%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.82",
          "val2": "0.23",
          "chgp": "256.52%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "16.73",
          "val2": "12.89",
          "chgp": "29.79%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "3.76%",
          "val2": "2.90%",
          "chgp": "0.86%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2024 is 4.77% vs 7.03% in Sep 2023",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": " Growth in half year ended Sep 2024 is 53.98% vs -94.81% in Sep 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "406.39",
          "val2": "387.89",
          "chgp": "4.77%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "15.14",
          "val2": "19.57",
          "chgp": "-22.64%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "1.60",
          "val2": "1.59",
          "chgp": "0.63%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "19.77",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "48.78",
          "val2": "31.68",
          "chgp": "53.98%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "3.73%",
          "val2": "5.05%",
          "chgp": "-1.32%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Standalone) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 6.89% vs 4.91% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 46.98% vs -92.84% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "611.13",
          "val2": "571.74",
          "chgp": "6.89%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "22.83",
          "val2": "24.91",
          "chgp": "-8.35%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "2.42",
          "val2": "1.82",
          "chgp": "32.97%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "19.77",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "65.51",
          "val2": "44.57",
          "chgp": "46.98%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "3.74%",
          "val2": "4.36%",
          "chgp": "-0.62%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2024 is 3.82% vs 21.00% in Mar 2023",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2024 is -90.18% vs 1,438.13% in Mar 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "752.79",
          "val2": "725.11",
          "chgp": "3.82%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "37.32",
          "val2": "31.35",
          "chgp": "19.04%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "2.76",
          "val2": "5.24",
          "chgp": "-47.33%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "595.05",
          "chgp": "-100.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "62.84",
          "val2": "639.71",
          "chgp": "-90.18%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "4.96%",
          "val2": "4.32%",
          "chgp": "0.64%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Standalone) - Dec'24 - YoYstock-summary
Dec'24
Dec'23
Change(%)
Net Sales
204.74
183.85
11.36%
Operating Profit (PBDIT) excl Other Income
7.69
5.34
44.01%
Interest
0.82
0.23
256.52%
Exceptional Items
0.00
0.00
Standalone Net Profit
16.73
12.89
29.79%
Operating Profit Margin (Excl OI)
3.76%
2.90%
0.86%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in quarter ended Dec 2024 is 11.36% vs 0.71% in Dec 2023

Direction Arrows
Standalone Net Profit

YoY Growth in quarter ended Dec 2024 is 29.79% vs 7.42% in Dec 2023

Half Yearly Results Snapshot (Standalone) - Sep'24stock-summary
Sep'24
Sep'23
Change(%)
Net Sales
406.39
387.89
4.77%
Operating Profit (PBDIT) excl Other Income
15.14
19.57
-22.64%
Interest
1.60
1.59
0.63%
Exceptional Items
19.77
0.00
Standalone Net Profit
48.78
31.68
53.98%
Operating Profit Margin (Excl OI)
3.73%
5.05%
-1.32%
Values in Rs Cr.
Direction Arrows
Net Sales

Growth in half year ended Sep 2024 is 4.77% vs 7.03% in Sep 2023

Direction Arrows
Standalone Net Profit

Growth in half year ended Sep 2024 is 53.98% vs -94.81% in Sep 2023

Nine Monthly Results Snapshot (Standalone) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
611.13
571.74
6.89%
Operating Profit (PBDIT) excl Other Income
22.83
24.91
-8.35%
Interest
2.42
1.82
32.97%
Exceptional Items
19.77
0.00
Standalone Net Profit
65.51
44.57
46.98%
Operating Profit Margin (Excl OI)
3.74%
4.36%
-0.62%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is 6.89% vs 4.91% in Dec 2023

Direction Arrows
Standalone Net Profit

YoY Growth in nine months ended Dec 2024 is 46.98% vs -92.84% in Dec 2023

Annual Results Snapshot (Standalone) - Mar'24stock-summary
Mar'24
Mar'23
Change(%)
Net Sales
752.79
725.11
3.82%
Operating Profit (PBDIT) excl Other Income
37.32
31.35
19.04%
Interest
2.76
5.24
-47.33%
Exceptional Items
0.00
595.05
-100.00%
Standalone Net Profit
62.84
639.71
-90.18%
Operating Profit Margin (Excl OI)
4.96%
4.32%
0.64%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2024 is 3.82% vs 21.00% in Mar 2023

Direction Arrows
Standalone Net Profit

YoY Growth in year ended Mar 2024 is -90.18% vs 1,438.13% in Mar 2023

stock-summaryCompany CV
About TTK Healthcare Ltd. stock-summary
stock-summary
TTK Healthcare Ltd.
Small Cap
Pharmaceuticals & Drugs
TTK Healthcare Limited, a TTK Group Company was incorporated in May 1958 as Orient Pharma and later renamed as TTK Pharma in Nov '81. The Company is the owner of famous Woodwards Gripewater brand. The Company operate into five main Strategic Business Units namely, Pharmaceuticals, Consumer Products, Medical Devices, Foods and Protective Devices divisions. It is engaged into Animal Welfare Products, Consumer Products, Medical Devices, Protective Devices and Foods Businesses.
Company Coordinates stock-summary
Company Details
6 Cathedral Road , Chennai Tamil Nadu : 600086
stock-summary
Tel: 91-44-28116106-28116110
stock-summary
info@ttkhealthcare.com
Registrar Details
Data Software Research Co Pvt Ltd , 9 Pycroft Garden Road, Off Haddows Road, Nungambakkam, Chennai